Inventor
YING WENBIN
US54 patents
⚠️ This page may combine multiple inventors who share the name “YING WENBIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NITTO DENKO CORP
28 patentsUS10047110B2Aug 14, 2018
RNA agents for GST-Pi gene modulation
NITTO DENKO CORP8 citations92
US10047111B2Aug 14, 2018
RNA interference agents for GST-PI gene modulation
NITTO DENKO CORP11 citations92
US9771582B2Sep 26, 2017
RNA interference compositions and methods for malignant tumors
NITTO DENKO CORP13 citations92
US9580710B2Feb 28, 2017
Methods and compositions for treating malignant tumors associated with KRAS mutation
NITTO DENKO CORP7 citations92
US9456984B2Oct 4, 2016
Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier
NITTO DENKO CORP10 citations84
USRE48887EJan 11, 2022
RNA interference compositions and methods for malignant tumors
NITTO DENKO CORP2 citations83
US10196637B2Feb 5, 2019
Retinoid-lipid drug carrier
NITTO DENKO CORP7 citations83
US10167253B2Jan 1, 2019
Ionizable compounds and compositions and uses thereof
NITTO DENKO CORP6 citations83
US10023597B2Jul 17, 2018
RNA interference agents for p21 gene modulation
NITTO DENKO CORP6 citations83
US9695206B2Jul 4, 2017
RNA interference agents for P21 gene modulation
NITTO DENKO CORP6 citations83
US9308267B2Apr 12, 2016
Lipids for therapeutic agent delivery formulations
NITTO DENKO CORP8 citations83
US10358647B2Jul 23, 2019
siRNA structures for high activity and reduced off target
NITTO DENKO CORP6 citations81
US10195145B2Feb 5, 2019
Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier
NITTO DENKO CORP4 citations73
US11737982B2Aug 29, 2023
Compositions and methods for nanoparticle lyophile forms
NITTO DENKO CORP2 citations72
US11384051B2Jul 12, 2022
Ionizable compounds and compositions and uses thereof
NITTO DENKO CORP2 citations72
US10792299B2Oct 6, 2020
Methods and compositions for treating malignant tumors associated with kras mutation
NITTO DENKO CORP3 citations72
US10441659B2Oct 15, 2019
Lipids for therapeutic agent delivery formulations
NITTO DENKO CORP3 citations72
US10300018B2May 28, 2019
Compositions and methods for nanoparticle lyophile forms
NITTO DENKO CORP4 citations72
US11926831B2Mar 12, 2024
SiRNA structures for high activity and reduced off target
NITTO DENKO CORP1 citations70
US11390871B2Jul 19, 2022
SiRNA structures for high activity and reduced off target
NITTO DENKO CORP3 citations70
US12311055B2May 27, 2025
Compositions and methods for nanoparticle lyophile forms
NITTO DENKO CORP0 citations62
USRE49431EFeb 28, 2023
RNA interference agents for GST-PI gene modulation
NITTO DENKO CORP0 citations62
USRE49229EOct 4, 2022
Methods and compositions for treating malignant tumors associated with KRAS mutation
NITTO DENKO CORP0 citations62
US11103583B2Aug 31, 2021
Lipids for therapeutic agent delivery formulations
NITTO DENKO CORP0 citations62
US11045488B2Jun 29, 2021
RNA interference agents for GST-π gene modulation
NITTO DENKO CORP0 citations62
US12440445B2Oct 14, 2025
Fusogenic compounds for delivery of biologically active molecules
NITTO DENKO CORP0 citations61
US12319643B2Jun 3, 2025
Ionizable compounds and compositions and uses thereof
NITTO DENKO CORP0 citations61
US11413243B2Aug 16, 2022
Fusogenic compounds for delivery of biologically active molecules
NITTO DENKO CORP1 citations61
AVANIR PHARMACEUTICALS
20 patentsUS7173036B2Feb 6, 2007
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AVANIR PHARMACEUTICALS45 citations96
US7084141B2Aug 1, 2006
Inhibitors of macrophase migration inhibitory factor and methods for identifying the same
AVANIR PHARMACEUTICALS27 citations96
US7514225B2Apr 7, 2009
Method for screening an agent that modulates activity of macrophage migration inhibitory factor
AVANIR PHARMACEUTICALS8 citations92
US7361760B2Apr 22, 2008
Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
AVANIR PHARMACEUTICALS31 citations92
US7105519B2Sep 12, 2006
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AVANIR PHARMACEUTICALS17 citations92
US7365200B2Apr 29, 2008
Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
AVANIR PHARMACEUTICALS9 citations84
US7312221B2Dec 25, 2007
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AVANIR PHARMACEUTICALS12 citations84
US7732146B2Jun 8, 2010
Method for screening an agent that modulates activity of macrophage migration inhibitory factor
AVANIR PHARMACEUTICALS3 citations73
US7435737B2Oct 14, 2008
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AVANIR PHARMACEUTICALS2 citations73
US7432374B2Oct 7, 2008
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AVANIR PHARMACEUTICALS2 citations73
US7312220B2Dec 25, 2007
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AVANIR PHARMACEUTICALS6 citations73
US7235546B2Jun 26, 2007
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AVANIR PHARMACEUTICALS7 citations73
US7192961B2Mar 20, 2007
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AVANIR PHARMACEUTICALS3 citations73
US7129236B2Oct 31, 2006
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AVANIR PHARMACEUTICALS5 citations73
US7238809B2Jul 3, 2007
Process for the preparation of inhibitors of macrophage migration inhibitory factor
AVANIR PHARMACEUTICALS1 citations62
US7235565B2Jun 26, 2007
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AVANIR PHARMACEUTICALS1 citations62
US7230106B2Jun 12, 2007
Process for the preparation of inhibitors of macrophage migration inhibitory factor
AVANIR PHARMACEUTICALS1 citations62
US7202248B2Apr 10, 2007
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AVANIR PHARMACEUTICALS1 citations62
US7157469B2Jan 2, 2007
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AVANIR PHARMACEUTICALS1 citations62
US7192955B2Mar 20, 2007
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
AVANIR PHARMACEUTICALS1 citations61
NIITSU YOSHIRO
2 patentsShowing the top 50 of 54 patents by PatentIndex Score.